Salomon & Ludwin’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.1K Sell
682
-5
-0.7% -$189 ﹤0.01% 903
2026
Q1
$24.7K Buy
687
+280
+69% +$10.2K ﹤0.01% 935
2025
Q4
$13.5K Buy
407
+186
+84% +$5.81K ﹤0.01% 1210
2025
Q3
$6.61K Buy
+221
New +$6.34K ﹤0.01% 1595

Other funds holding CRI

Salomon & Ludwin's CRI Position: Q2 2026 in Review

Salomon & Ludwin reduced its Carter's (CRI) stake by 0.73% in Q2 2026, selling an estimated $189 and leaving 682 shares worth $28.1K. The position accounts for ﹤0.01% of the portfolio, ranked #903.

Salomon & Ludwin first reported a position in CRI in Q3 2025 and has held it in 4 quarters since. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • Salomon & Ludwin held 682 shares of Carter's worth $28.1K as of Q2 2026.
  • Salomon & Ludwin sold 5 Carter's shares in Q2 2026, an estimated $189.
  • Carter's made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #903 holding.
  • Salomon & Ludwin first reported a position in Carter's in Q3 2025 and has held it in 4 quarters since.
  • 287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.